Eigen Therapeutics

Eigen Therapeutics is a biotechnology company based in Redwood City, California, founded in 2021.

The company focuses on enhancing cancer therapies by addressing tumor heterogeneity. It develops AI- and automation-enabled co-therapies that modify cancer cell states, making tumors easier to detect and treat while helping healthy cells endure the effects of treatment. The core offering of Eigen Therapeutics is a discovery platform that utilizes machine learning, robotics, and laboratory automation. This platform aims to identify combinations that improve targeted cancer therapies, develop combination therapies, and expand their application across various cancer types, including hematological malignancies. The company also works on therapies that modulate targets on cancer cells, enhancing the effectiveness of antigen-directed treatments like antibody-drug conjugates.